Renjing Biology
About:
Renjing Biotech is engaged in the research and development of drugs based on messenger ribonucleic acid.
Website: https://rinuagene.com/
Top Investors: K2VC, Chang'an Capital, Jiang Guangce
Description:
Renjing Biotechnology is a biopharmaceutical company. It also engages in the development of therapeutic tumor vaccines, tumor immunotherapy drugs, and protein substitutes, providing customers with advanced therapeutic solutions.
Total Funding Amount:
100M CNY
Headquarters Location:
Suzhou, Jiangsu, China
Founded Date:
2021-02-22
Contact Email:
rinuagene(AT)rinuagene.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-02-27
IPO Status:
Private
Industries:
© 2025 bioDAO.ai